Curaleaf Prepares to Enter 13th State

COLUMBUS, Ohio, Jan. 11, 2019 /PRNewswire/ -- PalliaTech Ohio, LLC, the Ohio affiliate of Curaleaf Holdings, Inc. (CSE: CURA) /OTCBB: CURLF), a leading vertically integrated cannabis operator, has been selected to receive a provisional medical cannabis processor license from the Ohio Department of Commerce. Curaleaf currently operates 10 processing facilities across the country and has a presence in 12 states, including managing 42 dispensaries. Curaleaf is recognized for its premium products and sets the standard for quality, care, and consistency within the industry. When the processing facility officially opens, medical cannabis patients in Ohio will have access to Curaleaf's diverse medical-grade products.

"Ohio's medical cannabis industry is still very nascent, and we are excited about the growth opportunity in the state. We look forward to bringing our premium products and services to the medical patients of Ohio," said Joe Lusardi, CEO of Curaleaf.

"So far in 2019, Curaleaf has opened two dispensaries in Florida, one in New York, and announced a management agreement with multiple dispensaries in Maryland. Our entry into Ohio furthers our multi-state operating strategy," Lusardi continued.

Curaleaf's new dispensaries have significantly expanded access to medical cannabis and are serving as a welcomed educational resource to patients and their respective communities.

The provisional license will be awarded upon successful completion of background checks of certain managers of Curaleaf's Ohio affiliate. Curaleaf expects the Ohio processing facility to be built out and receive its final certificate of operation within six months.

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (CSE: CURA) /OTCBB: CURLF) is the parent of Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 12 states. Curaleaf operates 42 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York. Curaleaf leverages its extensive research and development capabilities to distribute premium cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry's leading resource in education and advancement through research and advocacy.

Company Contact:

Curaleaf Holdings, Inc.

Christine Rigby, SVP, Investor Relations

PH: (781) 451-0145

[email protected]

Media Contact:

Samantha Qualls

[email protected]

212.889.0808

Investor Contact:

KCSA Strategic Communications

Valter Pinto, Managing Director

PH: (212) 896-1260

[email protected]

SOURCE Curaleaf Holdings, Inc.

Related Links

http://www.curaleaf.com

